Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
-
Published:2024-06
Issue:
Volume:72
Page:102596
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Levinsson Anna, Zolopa Camille, Vakili Farzaneh, Udhesister Sasha, Kronfli Nadine, Maheu-Giroux MathieuORCID, Bruneau Julie, Valerio Heather, Bajis Sahar, Read Phillip, Martró Elisa, Boucher Lisa, Morris Leith, Grebely JasonORCID, Artenie Adelina, Stone Jack, Vickerman Peter, Larney SarahORCID
Reference35 articles.
1. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review;Degenhardt;Lancet Global Health,2023 2. The contribution of injecting drug use as a risk factor for Hepatitis C virus transmission globally, regionally, and at country level: a modelling study;Trickey;Lancet Gastroenterol Hepatol,2019 3. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection;Grebely;Hepatology,2014 4. A global systematic review and meta-analysis of the incidence of HIV and hepatitis C virus (HCV) among people who inject drugs, and associations with age and sex or gender;Artenie;Lancet Gastroenterol Hepatol,2023 5. A global meta-analysis of the prevalence of HIV, hepatitis C virus and hepatitis B virus among people who inject drugs - do gender-based differences vary by country-level indicators?;Leung;J Infect Dis,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|